Lidia Sánchez-Puebla

Mrs. Lidia Sánchez-Puebla

Ramón Castroviejo Eye Research Institute
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Life
Verified
Journal Article
Open access
PDF file
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
Lorena Elvira-HurtadoLorena Elvira-Hurtado
Lorena Elvira-Hurtado
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Lidia Sánchez-PueblaLidia Sánchez-Puebla
Lidia Sánchez-Puebla
Rosa de Hoz MontañanaRosa de Hoz Montañana
Rosa de Hoz Montañana
Preclinical Alzheimer’s disease (AD) includes cognitively healthy subjects with at least one positive biomarker: reduction in cerebrospinal fluid Aβ42 or visualization of cerebral amyloidosis by positron emission tomography imaging. The use of these biomarkers is expensive, invasive, and not always possible. It has been shown that the retinal changes measured by optical coherence tomography (OCT) and OCT-angiography (OCTA) could be biomarkers of AD. Diagnosis in early stages before irreversible AD neurological damage takes place is important for the development of new therapeutic interventions. In this review, we summarize the findings of different published studies using OCT and OCTA in participants with preclinical AD. To date, there have been few studies on this topic and they are methodologically very dissimilar. Moreover, these include only two longitudinal studies. For these reasons, it would be interesting to unify the methodology, make the inclusion criteria more rigorous, and conduct longer longitudinal studies to assess the evolution of these subjects. If the results were consistent across repeated studies with the same methodology, this could provide us with insight into the value of the retinal changes observed by OCT/OCTA as potential reliable, cost-effective, and noninvasive biomarkers of preclinical AD.

19 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Rosa de Hoz MontañanaRosa de Hoz Montañana
Rosa de Hoz Montañana
JMJose Antonio Jose A Matamoros
Jose Antonio Jose A Matamoros
LCLejing Chen
Lejing Chen
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
Macroglia (astrocytes and Müller glia) may play an important role in the pathogenesis of glaucoma. In a glaucoma mouse model, we studied the effects of unilateral laser-induced ocular hypertension (OHT) on macroglia in OHT and contralateral eyes at different time points after laser treatment (1, 3, 5, 8 and 15 days) using anti-GFAP and anti-MHC-II, analyzing the morphological changes, GFAP-labelled retinal area (GFAP-PA), and GFAP and MHC-II immunoreactivity intensities ((GFAP-IRI and MHC-II-IRI)). In OHT and contralateral eyes, with respect to naïve eyes, at all the time points, we found the following: (i) astrocytes with thicker somas and more secondary processes, mainly in the intermediate (IR) and peripheral retina (PR); (ii) astrocytes with low GFAP-IRI and only primary processes near the optic disc (OD); (iii) an increase in total GFAP-RA, which was higher at 3 and 5 days, except for at 15 days; (iv) an increase in GFAP-IRI in the IR and especially in the PR; (v) a decrease in GFAP-IRI near the OD, especially at 1 and 5 days; (vi) a significant increase in MHC-II-IRI, which was higher in the IR and PR; and (vii) the Müller glia were GFAP+ and MHC-II+. In conclusion, in this model of glaucoma, there is a bilateral macroglial activation maintained over time involved in the inflammatory glaucoma process.

Verified
Journal Article
Open access
PDF file
CGClaudia García
Claudia García
Verónica GarcíaVerónica García
Verónica García
JMJose Antonio Jose A Matamoros
Jose Antonio Jose A Matamoros
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
JUAN J. SALAZARJUAN J. SALAZAR
JUAN J. SALAZAR
Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration are common retinal diseases responsible for most of the blindness causes in the working-age and elderly populations in developed countries. Many of the current treatments used in these pathologies fail to stop or slow the progression of the disease. Therefore, other types of treatments with neuroprotective characteristics may be necessary to allow a more satisfactory management of the disease. Citicoline and coenzyme Q10 are molecules that have neuroprotective, antioxidant, and anti-inflammatory properties, and their use could have a beneficial effect in ocular neurodegenerative pathologies. This review provides a compilation, mainly from the last 10 years, of the main studies that have been published on the use of these drugs in these neurodegenerative diseases of the retina, analyzing the usefulness of these drugs in these pathologies.

Verified
Journal Article
Open access
PDF file
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
Lidia Sánchez-PueblaLidia Sánchez-Puebla
Lidia Sánchez-Puebla
EEEva Espejel
Eva Espejel
LALucía García del Arco
Lucía García del Arco
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
In 103 subjects with a high genetic risk of developing Alzheimer’s disease (AD), family history (FH) of AD and ApoE ɛ4 characterization (ApoE ɛ4) were analyzed for changes in the retinal vascular network by OCTA (optical coherence tomography angiography), and AngioTool and Erlangen-Angio-Tool (EA-Tool) as imaging analysis software. Retinal vascularization was analyzed by measuring hypercholesterolemia (HCL) and high blood pressure (HBP). Angio-Tool showed a statistically significant higher percentage of area occupied by vessels in the FH+ ApoE ɛ4- group vs. in the FH+ ApoE ɛ4+ group, and EA-Tool showed statistically significant higher vascular densities in the C3 ring in the FH+ ApoE ɛ4+ group when compared with: i)FH- ApoE ɛ4- in sectors H3, H4, H10 and H11; and ii) FH+ ApoE ɛ4- in sectors H4 and H12. In participants with HCL and HBP, statistically significant changes were found, in particular using EA-Tool, both in the macular area, mainly in the deep plexus, and in the peripapillary area. In conclusion, OCTA in subjects with genetic risk factors for the development of AD showed an apparent increase in vascular density in some sectors of the retina, which was one of the first vascular changes detectable. These changes constitute a promising biomarker for monitoring the progression of pathological neuronal degeneration.

27 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Lidia Sánchez-PueblaLidia Sánchez-Puebla
Lidia Sánchez-Puebla
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Rosa de Hoz MontañanaRosa de Hoz Montañana
Rosa de Hoz Montañana
The murine models of Alzheimer’s disease (AD) have advanced our understanding of the pathophysiology. In vivo studies of the retina using optical coherence tomography (OCT) have complemented histological methods; however, the lack of standardisation in OCT methodologies for murine models of AD has led to significant variations in the results of different studies. A literature search in PubMed and Scopus has been performed to review the different methods used in these models using OCT and to analyse the methodological characteristics of each study. In addition, some recommendations are offered to overcome the challenges of using OCT in murine models. The results reveal a lack of consensus on OCT device use, retinal area analysed, segmentation techniques, and analysis software. Although some studies use the same OCT device, variations in other parameters make the direct comparison of results difficult. Standardisation of retinal analysis criteria in murine models of AD using OCT is crucial to ensure consistent and comparable results. This implies the application of uniform measurement and segmentation protocols. Despite the absence of standardisation, OCT has proven valuable in advancing our understanding of the pathophysiology of AD.

Verified
Journal Article
Open access
PDF file
Lidia Sánchez-PueblaLidia Sánchez-Puebla
Lidia Sánchez-Puebla
Rosa de Hoz MontañanaRosa de Hoz Montañana
Rosa de Hoz Montañana
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
AAAlberto Arias-Vázquez
Alberto Arias-Vázquez
MJMaria Gonzalez Jimenez
Maria Gonzalez Jimenez
José M RamírezJosé M Ramírez
José M Ramírez
In Alzheimer’s disease (AD), transgenic mouse models have established links between abnormalities in the retina and those in the brain. APPNL-F/NL-F is a murine, humanized AD model that replicates several pathological features observed in patients with AD. Research has focused on obtaining quantitative parameters from optical coherence tomography (OCT) in AD. The aim of this study was to analyze, in a transversal case-control study using manual retinal segmentation via SD-OCT, the changes occurring in the retinal layers of the APPNL/F-NF/L AD model in comparison to C57BL/6J mice (WT) at 6, 9, 12, 15, 17, and 20 months of age. The analysis focused on retinal thickness in RNFL-GCL, IPL, INL, OPL, and ONL based on the Early Treatment Diabetic Retinopathy Study (ETDRS) sectors. Both APPNL-F/NL-F-model and WT animals exhibited thickness changes at the time points studied. While WT showed significant changes in INL, OPL, and ONL, the AD model showed changes in all retinal layers analyzed. The APPNL-F/NL-F displayed significant thickness variations in the analyzed layers except for the IPL compared to related WT. These thickness changes closely resembled those found in humans during preclinical stages, as well as during mild and moderate AD stages, making this AD model behave more similarly to the disease in humans.